Follicular lymphoma grade 3B is a distinct neoplasm according to cytogenetic and immunohistochemical profiles

Haematologica

Volumn 96, Issue 9, 2011, Pages 1327-1334

  Horn, Heike ^a   Schmelter, Christopher ^b   Leich, Ellen ^b   Salaverria, Itziar ^c   Katzenberger, Tiemo ^d   Ott, M Michaela ^e   Kalla, Jörg ^a   Romero, Monica ^f   Siebert, Reiner ^c   Rosenwald, Andreas ^b   Ott, German ^a  

^a DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY OF KIEL   (Germany)

^d KLINIKUM ASCHAFFENBURG   (Germany)

^e CARITAS KRANKENHAUS   (Germany)

^f HOSPITAL GENERAL DE MÉXICO   (Mexico)

Author keywords

Fish; Follicular lymphoma; Genetics; Grade 3b; Immunohistochemistry

Indexed keywords

COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; IMMUNOGLOBULIN LIGHT CHAIN; INTERFERON REGULATORY FACTOR 4; PROTEIN BCL 2;

ADOLESCENT; ADULT; AGED; ARTICLE; BCL2 GENE; BCL6 GENE; CANCER CLASSIFICATION; CANCER GRADING; CENTROCYTE; CHILD; CONTROLLED STUDY; CYTOGENETICS; FEMALE; FOLLICULAR LYMPHOMA; GENE EXPRESSION; GENE LOCUS; GENE TRANSLOCATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IRF4 GENE; LARGE CELL LYMPHOMA; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; ONCOGENE MYC; SCHOOL CHILD; TUMOR CELL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHROMOSOME BREAKAGE; CYTOGENETIC ANALYSIS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPHOMA, FOLLICULAR; MIDDLE AGED; NEOPLASM GRADING; PROTO-ONCOGENE PROTEINS; TRANSLOCATION, GENETIC; YOUNG ADULT;

EID: 80052385495     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2011.042531     Document Type: Article

References (28)

1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Thiele J, et al. (editors). World Health Organization Classification of Tumours of Haematopoietic and Lymphoid tissues. Lyon: IARC Press. 2008.
2. Katzenberger T, Kalla J, Leich E, Stöcklein H, Hartmann E, Barnickel S, et al. A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36. Blood. 2009;113(5):1053-61.
3. Klapper W, Szczepanowski M, Burkhardt B, Berger H, Rosolowski M, Bentink S, et al. Molecular profiling of pediatric mature Bcell lymphoma treated in population-based prospective clinical trials. Blood. 2008;112 (4):1374-81.
4. Oschlies I, Salaverria I, Mahn F, Meinhardt A, Zimmermann M, Woessmann W, et al. Pediatric follicular lymphoma -a clinicopathological study of a population-based series of patients treated within the NHLBFM (Berlin-Frankfurt-Munster) multicenter trials. Haematologica. 2010;95(2):253-9.
5. Bosga-Bouwer AG, van Imhoff GW, Boonstra R, van der Veen A, Haralambieva E, van den Berg A, et al. Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t(14;18), 3q27, or other translocations: t(14;18) and 3q27 are mutually exclusive. Blood. 2003;101(3):1149-54.
6. Bosga-Bouwer AG, van den BA, Haralambieva E, de Jong D, Boonstra R, Kluin P, et al. Molecular, cytogenetic, and immunophenotypic characterization of follicular lymphoma grade 3B; a separate entity or part of the spectrum of diffuse large Bcell lymphoma or follicular lymphoma? Hum Pathol. 2006;37(5):528-33.
7. Chau I, Jones R, Cunningham D, Wotherspoon A, Maisey N, Norman AR, et al. Outcome of follicular lymphoma grade 3: is anthracycline necessary as front-line therapy? Br J Cancer. 2003;89(1):36-42.
8. Karube K, Guo Y, Suzumiya J, Sugita Y, Nomura Y, Yamamoto K, et al. CD10- MUM1+ follicular lymphoma lacks BCL2 gene translocation and shows characteristic biologic and clinical features. Blood. 2007;109(7):3076-9.
9. Karube K, Ying G, Tagawa H, Niino D, Aoki R, Kimura Y, et al. BCL6 gene amplifica tion/3q27 gain is associated with unique clinicopathological characteristics among follicular lymphoma without BCL2 gene translocation. Mod Pathol. 2008;21(8):973-8.
10. Katzenberger T, Ott G, Klein T, Kalla J, Müller-Hermelink HK, Ott MM. Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component. Am J Pathol. 2004;165(2):481-90.
11. Ott G, Katzenberger T, Lohr A, Kindelberger S, Rüdiger T, Wilhelm M, et al. Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3. Blood. 2002;99(10):3806-12.
12. Piccaluga PP, Califano A, Klein U, Agostinelli C, Bellosillo B, Gimeno E, et al. Gene expression analysis provides a potential rationale for revising the histological grading of follicular lymphomas. Haematologica. 2008;93(7):1033-8.
13. Shustik J, Quinn M, Connors JM, Gascoyne RD, Skinnider B, Sehn LH. Follicular non- Hodgkin lymphoma grades 3A and 3B have a similar outcome and appear incurable with anthracycline-based therapy. Ann Oncol. 2011;22(5):1164-9.
14. Lennert K, Feller A. Histopathology of Non- Hodgkin's Lymphomas. New York: Springer Verlag; 1992.
15. Wang SA, Wang L, Hochberg EP, Muzikansky A, Harris NL, Hasserjian RP, et al. Low histologic grade follicular lymphoma with high proliferation index: morphologic and clinical features. Am J Surg Pathol. 2005;29 (11):1490-6.
16. Höller S, Horn H, Lohr A, Mäder U, Katzenberger T, Kalla J, et al. A cytomorphological and immunohistochemical profile of aggressive B-cell lymphoma: high clinical impact of a cumulative immunohistochemical outcome predictor score. J Hematop. 2009;2(4):187-94.
17. Haralambieva E, Kleiverda K, Mason DY, Schuuring E, Kluin PM. Detection of three common translocation breakpoints in non- Hodgkin's lymphomas by fluorescence in situ hybridization on routine paraffinembedded tissue sections. J Pathol. 2002;198(2):163-70.
18. Salaverria I, Philipp C, Oschlies I, Kohler CW, Kreuz M, Szczepanowski M, et al. Translocations activating IRF4 identify a subtype of germinal-center-derived B-cell lymphoma affecting predominantly children and young adults. Blood. 2011;118(1): 139-47.
19. Leich E, Salaverria I, Bea S, Zettl A, Wright G, Moreno V, et al. Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations. Blood. 2009;114(4):826-34.
20. Hsi ED, Mirza I, Lozanski G, Hill J, Pohlman B, Karafa MT, et al. A clinicopathologic evaluation of follicular lymphoma grade 3A versus grade 3B reveals no survival differences. Arch Pathol Lab Med. 2004;128(8):863-8.
21. Au WY, Horsman DE, Gascoyne RD, Viswanatha DS, Klasa RJ, Connors JM, et al. The spectrum of lymphoma with 8q24 aberrations: a clinical, pathological and cytogenetic study of 87 consecutive cases. Leuk Lymphoma. 2004;45(3):519-28.
22. Christie L, Kernohan N, Levison D, Sales M, Cunningham J, Gillespi K, et al. C-MYC translocation in t(14;18) positive follicular lymphoma at presentation: An adverse prognostic indicator? Leuk Lymphoma. 2008;49(3):470-6.
23. Mohamed AN, Palutke M, Eisenberg L, Al- Katib A. Chromosomal analyses of 52 cases of follicular lymphoma with t(14;18), including blastic/blastoid variant. Cancer Genet Cytogenet. 2001;126(1):45-51.
24. Offit K, Wong G, Filippa DA, Tao Y, Chaganti RS. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: clinical correlations. Blood. 1991;77(7):1508-15.
25. Yano T, Jaffe ES, Longo DL, Raffeld M. MYC rearrangements in histologically progressed follicular lymphomas. Blood. 1992;80(3):758-67.
26. Aukema SM, Siebert R, Schuuring E, van Imhoff GW, Kluin-Nelemans HC, Boerma EJ, Kluin PM. Double hit B-cell lymphomas. Blood. 2011;117(8):2319-31.
27. Snuderl M, Kolman OK, Chen YB, Hsu JJ, Ackerman AM, Dal CP, et al. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma. Am J Surg Pathol. 2010;34(3):327-40.
28. Hans CP, Weisenburger DD, Vose JM, Hock LM, Lynch JC, Aoun P, et al. A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival. Blood. 2003;101(6):2363-7.